Kouhei Tsumoto Selected Research

Kouhei Tsumoto Research Topics

Disease

37	Neoplasms (Cancer) 12/2023 - 03/2002
12	Infections 10/2023 - 06/2002
5	Carcinoma (Carcinomatosis) 01/2021 - 03/2002
5	Stomach Neoplasms (Stomach Cancer) 01/2021 - 12/2014
4	Glioma (Gliomas) 12/2014 - 06/2010
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2019
3	Brain Neoplasms (Brain Tumor) 04/2023 - 09/2011
3	Inflammation (Inflammations) 01/2023 - 01/2016
3	Breast Neoplasms (Breast Cancer) 10/2019 - 08/2015
3	Glioblastoma (Glioblastoma Multiforme) 03/2016 - 09/2011
2	Anaphylaxis (Anaphylactic Shock) 12/2023 - 11/2023
2	Hypersensitivity (Allergy) 12/2023 - 11/2023
2	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 01/2023
2	Atypical Hemolytic Uremic Syndrome 08/2022 - 01/2022
2	Parkinson Disease (Parkinson's Disease) 11/2021 - 01/2018
2	Hemolysis 01/2021 - 05/2012
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 06/2009
2	Virus Diseases (Viral Diseases) 05/2015 - 06/2002
2	Atherosclerosis 01/2015 - 08/2012
1	Rheumatoid Arthritis 04/2024
1	Asthma (Bronchial Asthma) 12/2023
1	Fibrosis (Cirrhosis) 11/2023
1	Medulloblastoma 04/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Dementia (Dementias) 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Hemorrhage 11/2021
1	Osteosarcoma (Osteogenic Sarcoma) 07/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 04/2023 - 02/2003
9	AntibodiesIBA 12/2023 - 06/2004
7	AntigensIBA 12/2023 - 03/2005
6	Cadherins (E-Cadherin)IBA 01/2023 - 08/2012
4	IronIBA 01/2022 - 05/2012
4	Peptides (Polypeptides)IBA 07/2021 - 01/2018
3	ProteomeIBA 12/2023 - 01/2019
3	Therapeutic UsesIBA 12/2023 - 11/2021
3	LigandsIBA 04/2023 - 01/2016
3	Immunoglobulin G (IgG)IBA 01/2023 - 12/2014
3	EpitopesIBA 01/2023 - 09/2017
3	Messenger RNA (mRNA)IBA 11/2022 - 06/2010
3	ErbB Receptors (EGF Receptor)IBA 11/2021 - 01/2016
3	InterferonsIBA 01/2015 - 09/2011
3	CytokinesIBA 05/2010 - 03/2005
3	Interleukin-2 (IL2)IBA 07/2006 - 03/2002
3	Indicators and Reagents (Reagents)IBA 07/2006 - 03/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024 - 06/2004
2	Interleukin-11 (Interleukin 11)IBA 11/2023 - 02/2017
2	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2023
2	Lysine (L-Lysine)FDA Link 11/2022 - 01/2020
2	Histones (Histone)IBA 11/2022 - 09/2014
2	Arginine (L-Arginine)FDA Link 11/2022 - 12/2021
2	Complement Factor H (Factor H)IBA 08/2022 - 01/2022
2	OligonucleotidesIBA 05/2021 - 12/2014
2	Heme (Haem)IBA 01/2021 - 01/2016
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021 - 09/2017
2	Single-Chain AntibodiesIBA 01/2021 - 12/2014
2	Monoclonal AntibodiesIBA 01/2020 - 03/2015
2	Calcium-Binding ProteinsIBA 01/2019 - 03/2013
2	Epidermal Growth Factor (EGF)IBA 01/2016 - 01/2016
2	Polysaccharides (Glycans)IBA 10/2015 - 05/2012
2	Alkylating AgentsIBA 09/2011 - 06/2010
2	Temozolomide (Temodar)FDA LinkGeneric 09/2011 - 06/2010
2	Bispecific AntibodiesIBA 07/2006 - 03/2002
1	AllergensIBA 12/2023
1	Glutaral (Glutaraldehyde)IBA 12/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2023
1	Vorinostat FDA Link 12/2023
1	MannansIBA 12/2023
1	MetalsIBA 10/2023
1	titanium dioxide (Titania)FDA Link 10/2023
1	UbiquitinIBA 04/2023
1	Carrier Proteins (Binding Protein)IBA 04/2023
1	Drug CarriersIBA 04/2023
1	MicellesIBA 04/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Amino Acids FDA Link 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Small Leucine-Rich ProteoglycansIBA 11/2022
1	Extracellular Matrix ProteinsIBA 11/2022
1	Histone Deacetylase InhibitorsIBA 11/2022
1	Proline (L-Proline)FDA Link 11/2022
1	Leucine-Rich Repeat ProteinsIBA 11/2022
1	AutoantibodiesIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	DisintegrinsIBA 11/2021
1	ThrombospondinsIBA 11/2021
1	Metalloproteases (Metalloproteinases)IBA 11/2021
1	antineoplaston A10 (A 10)IBA 11/2021
1	A-Form DNA (A-DNA)IBA 05/2021

Therapy/Procedure

11	Therapeutics 01/2023 - 07/2006
5	Immunotherapy 12/2023 - 03/2002
3	Drug Therapy (Chemotherapy) 12/2023 - 09/2011
1	Biological Therapy 04/2024